Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01420328 · ClinicalTrials.gov registry record · NA
To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects
A NA study, sponsored by University at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01420328 is a NA study that has completed, run by University at Buffalo. The registered enrollment target is 20 participants.
The verdict
NCT01420328, a NA study, has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study focuses on the use of Vytorin to study inflammatory markers in subjects with normal cholesterol.
Interventions
- DRUG Placebo
- DRUG Vytorin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-05-01 |
| Est. Completion | 2016-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01420328
The ClinicalTrials.gov registry entry for NCT01420328 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01420328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01420328 about?
NCT01420328 is a clinical study titled "To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects". This study focuses on the use of Vytorin to study inflammatory markers in subjects with normal cholesterol.
What is the current status of trial NCT01420328?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-05-01. Estimated completion is 2016-07-01.
What interventions are being tested in trial NCT01420328?
The interventions under investigation include: Placebo (DRUG), Vytorin (DRUG).
Who is sponsoring clinical trial NCT01420328?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.